Skip to main content

Risk factors for breast cancer from benign breast disease in a diverse population

Breast Cancer Research and Treatment volume 118, pages 1–7 (2009)Cite this article

Abstract

Background The majority of studies have reported risks of breast cancer (BC) from benign breast disease (BBD) in essentially homogenous Caucasian populations. Information on breast cancer risk factors in larger, multi-ethnic populations should facilitate the development of appropriate and targeted risk reduction strategies. Design Cases and controls were drawn from a parent BBD cohort of 4,970 women, 1,341 African–Americans (AA) and 3,629 non-AA who were diagnosed with BBD after examination of an excisional breast biopsy. Risk factors (34 variables) included demographics, lesion types, and epidemiological variables. Results The final multivariable model retained significance (P < 0.05) for lesion risk-level, fibroadenoma, and the interaction of age-by-race. Women with proliferative lesions (no atypia, risk level 2) were 1.7 times more likely to develop BC when compared with women with non-proliferative lesions (OR = 1.7, 95% CI 1.13, 2.42, P = 0.009). Women with atypia (risk level 3) were 3.75 times more likely to develop BC compared to women with non-proliferative lesions (OR = 3.75, 95% CI 1.99, 7.06, P < 0.001). The odds of breast cancer was approximately 35% lower among women with fibroadenoma as compared to women without fibroadenoma (OR = 0.65, 95% CI 0.46, 0.94, P = 0.020). AA women with BBD who were 50 years or older were 2.28 times more likely to develop breast cancer as compared to non-AA women who were less than 50 years old (OR = 2.28, 95% CI 1.34, 3.88, P = 0.002). Conclusion Women with fibroadenoma (nonproliferative or proliferative) were less likely to progress to BC. Older AA women are at greater risk for progression to breast cancer from BBD.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price includes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1

References

  1. Schnitt SJ (2003) Benign breast disease and breast cancer risk: morphology and beyond. Am J Surg Pathol 27:836–841. doi:10.1097/00000478-200306000-00017

    Article  PubMed  Google Scholar 

  2. Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ, Johnson J, Blake C, Tlsty T, Vachon CM, Melton LJIII, Visscher DW (2005) Benign breast disease and the risk of breast cancer. N Engl J Med 353:229–237. doi:10.1056/NEJMoa044383

    Article  CAS  PubMed  Google Scholar 

  3. Worsham MJ, Abrams J, Raju U, Kapke A, Lu M, Cheng J, Mott D, Wolman SR (2007) Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population. Breast J 13:115–121. doi:10.1111/j.1524-4741.2007.00388.x

    Article  PubMed  Google Scholar 

  4. Worsham MJ, Raju U, Lu M, Kapke A, Cheng J, Wolman SR (2007) Multiplicity of benign breast lesions is a risk factor for progression to breast cancer. Clin Cancer Res 13:5474–5479. doi:10.1158/1078-0432.CCR-07-0928

    Article  CAS  PubMed  Google Scholar 

  5. Marshall LM, Hunter DJ, Connolly JL, Schnitt SJ, Byrne C, London SJ, Colditz GA (1997) Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev 6:297–301

    CAS  PubMed  Google Scholar 

  6. Newman LA, Griffith KA, Jatoi I, Simon MS, Crowe JP, Colditz GA (2006) Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol 24:1342–1349. doi:10.1200/JCO.2005.03.3472

    Article  PubMed  Google Scholar 

  7. Ghafoor A, Jemal A, Ward E, Cokkinides V, Smith R, Thun M (2003) Trends in breast cancer by race and ethnicity. CA Cancer J Clin 53:342–355

    Article  PubMed  Google Scholar 

  8. Sanders ME, Page DL, Simpson JF, Schuyler PA, Dale Plummer W, Dupont WD (2006) Interdependence of radial scar and proliferative disease with respect to invasive breast carcinoma risk in patients with benign breast biopsies. Cancer 106:1453–1461. doi:10.1002/cncr.21730

    Article  PubMed  Google Scholar 

  9. Degnim AC, Visscher DW, Berman HK, Frost MH, Sellers TA, Vierkant RA, Maloney SD, Pankratz VS, de Groen PC, Lingle WL, Ghosh K, Penheiter L, Tlsty T, Melton LJIII, Reynolds CA, Hartmann LC (2007) Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol 25:2671–2677. doi:10.1200/JCO.2006.09.0217

    Article  PubMed  Google Scholar 

  10. Dupont WD, Page DL (1985) Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312:146–151

    CAS  PubMed  Google Scholar 

  11. Krieger N, Hiatt RA (1992) Risk of breast cancer after benign breast diseases. Variation by histologic type, degree of atypia, age at biopsy, and length of follow-up. Am J Epidemiol 135:619–631

    CAS  PubMed  Google Scholar 

  12. Carter CL, Corle DK, Micozzi MS, Schatzkin A, Taylor PR (1988) A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol 128:467–477

    CAS  PubMed  Google Scholar 

  13. London SJ, Connolly JL, Schnitt SJ, Colditz GA (1992) A prospective study of benign breast disease and the risk of breast cancer. JAMA 267:941–944. doi:10.1001/jama.267.7.941

    Article  CAS  PubMed  Google Scholar 

  14. Dupont WD, Parl FF, Hartmann WH, Brinton LA, Winfield AC, Worrell JA, Schuyler PA, Plummer WD (1993) Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 71:1258–1265. doi:10.1002/1097-0142(19930215)71:4<1258::AID-CNCR2820710415>3.0.CO;2-I

    Google Scholar 

  15. Dupont WD, Page DL, Parl FF, Plummer WD Jr, Schuyler PA, Kasami M, Jensen RA (1999) Estrogen replacement therapy in women with a history of proliferative breast disease. Cancer 85:1277–1283. doi:10.1002/(SICI)1097-0142(19990315)85:6<1277::AID-CNCR9>3.0.CO;2-E

    Google Scholar 

  16. Jacobs TW, Byrne C, Colditz G, Connolly JL, Schnitt SJ (1999) Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med 340:430–436. doi:10.1056/NEJM199902113400604

    Article  CAS  PubMed  Google Scholar 

  17. Cheng J, Qiu S, Raju U, Wolman SR, Worsham MJ (2008) Benign breast disease heterogeneity: association with histopathology, age, and ethnicity. Breast Cancer Res Treat 111:289–296. doi:10.1007/s10549-007-9775-5

    Article  PubMed  Google Scholar 

  18. Ford ME, Hill DD, Blount A, Morrison J, Worsham M, Havstad SL, Johnson CC (2002) Modifying a breast cancer risk factor survey for African American women. Oncol Nurs Forum 29:827–834. doi:10.1188/02.ONF.827-834

    Article  PubMed  Google Scholar 

  19. Dupont WD, Page DL (1989) Relative risk of breast cancer varies with time since diagnosis of atypical hyperplasia. Hum Pathol 20:723–725. doi:10.1016/0046-8177(89)90063-4

    Article  CAS  PubMed  Google Scholar 

  20. Tamimi RM, Byrne C, Baer HJ, Rosner B, Schnitt SJ, Connolly JL, Colditz GA (2005) Benign breast disease, recent alcohol consumption, and risk of breast cancer: a nested case—control study. Breast Cancer Res 7:R555–R562. doi:10.1186/bcr1039

    Article  CAS  PubMed  Google Scholar 

  21. Cowan DF (1989) H. T. Involution of the breast in women aged 50 to 104 years: a histopathological study of 102 cases. Surg Pathol 2:323–333

    Google Scholar 

  22. Hutson SW, Cowen PN, Bird CC (1985) Morphometric studies of age related changes in normal human breast and their significance for evolution of mammary cancer. J Clin Pathol 38:281–287. doi:10.1136/jcp.38.3.281

    Article  CAS  PubMed  Google Scholar 

  23. Milanese TR, Hartmann LC, Sellers TA, Frost MH, Vierkant RA, Maloney SD, Pankratz VS, Degnim AC, Vachon CM, Reynolds CA, Thompson RA, Melton LJIII, Goode EL, Visscher DW (2006) Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst 98:1600–1607

    PubMed  Article  Google Scholar 

  24. Henson DE, Tarone RE (1994) Involution and the etiology of breast cancer. Cancer 74:424–429. doi:10.1002/1097-0142(19941001)74:7<1974::AID-CNCR2820740724>3.0.CO;2-0

    Google Scholar 

  25. Dupont WD, Page DL, Parl FF, Vnencak-Jones CL, Plummer WD Jr, Rados MS, Schuyler PA (1994) Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med 331:10–15. doi:10.1056/NEJM199407073310103

    Article  CAS  PubMed  Google Scholar 

  26. Foxcroft LM, Evans EB, Porter AJ (2004) The diagnosis of breast cancer in women younger than 40. Breast 13:297–306. doi:10.1016/j.breast.2004.02.012

    Article  CAS  PubMed  Google Scholar 

  27. Markopoulos C, Kouskos E, Mantas D, Kontzoglou K, Antonopoulou K, Revenas Z, Kyriakou V (2004) Fibroadenomas of the breast: is there any association with breast cancer? Eur J Gynaecol Oncol 25:495–497

    CAS  PubMed  Google Scholar 

  28. Sklair-Levy M, Sella T, Alweiss T, Craciun I, Libson E, Mally B (2008) Incidence and management of complex fibroadenomas. AJR Am J Roentgenol 190:214–218. doi:10.2214/AJR.07.2330

    Article  PubMed  Google Scholar 

  29. McDivitt RW, Stevens JA, Lee NC, Wingo PA, Rubin GL, Gersell D (1992) Histologic types of benign breast disease and the risk for breast cancer. The cancer and steroid hormone study group. Cancer 69:1408–1414. doi:10.1002/1097-0142(19920315)69:6<1408::AID-CNCR2820690617>3.0.CO;2-C

    Google Scholar 

  30. Ashbeck EL, Rosenberg RD, Stauber PM, Key CR (2007) Benign breast biopsy diagnosis and subsequent risk of breast cancer. Cancer Epidemiol Biomarkers Prev 16:467–472. doi:10.1158/1055-9965.EPI-06-0394

    Article  PubMed  Google Scholar 

  31. Wang DY, Fentiman IS (1985) Epidemiology and endocrinology of benign breast disease. Breast Cancer Res Treat 6:5–36. doi:10.1007/BF01806008

    Article  CAS  PubMed  Google Scholar 

  32. Rohan TE, Jain M, Miller AB (1998) Alcohol consumption and risk of benign proliferative epithelial disorders of the breast: a case–cohort study. Public Health Nutr 1:139–145. doi:10.1079/PHN19980023

    Article  CAS  PubMed  Google Scholar 

  33. Rohan TE, Jain M, Miller AB (1998) A case–cohort study of diet and risk of benign proliferative epithelial disorders of the breast (Canada). Cancer Causes Control 9:19–27. doi:10.1023/A:1008841118358

    Article  CAS  PubMed  Google Scholar 

  34. Brinton LA (1990) Relationship of benign breast disease to breast cancer. Ann N Y Acad Sci 586:266–271. doi:10.1111/j.1749-6632.1990.tb17815.x

    Article  CAS  PubMed  Google Scholar 

  35. Thomas DB, Persing JP, Hutchinson WB (1982) Exogenous estrogens and other risk factors for breast cancer in women with benign breast diseases. J Natl Cancer Inst 69:1017–1025

    CAS  PubMed  Google Scholar 

  36. Dupont WD, Page DL, Rogers LW, Parl FF (1989) Influence of exogenous estrogens, proliferative breast disease, and other variables on breast cancer risk. Cancer 63:948–957. doi:10.1002/1097-0142(19890301)63:5<948::AID-CNCR2820630527>3.0.CO;2-U

    Google Scholar 

  37. Byrne C, Connolly JL, Colditz GA, Schnitt SJ (2000) Biopsy confirmed benign breast disease, postmenopausal use of exogenous female hormones, and breast carcinoma risk. Cancer 89:2046–2052. doi:10.1002/1097-0142(20001115)89:10<2046::AID-CNCR3>3.0.CO;2-F

    Google Scholar 

  38. Rosenberg L, Miller DR, Helmrich SP, Kaufman DW, Schottenfeld D, Stolley PD, Shapiro S (1985) Breast cancer and the consumption of coffee. Am J Epidemiol 122:391–399

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This research was supported by NIH CA 70923 (MJW) and ACS EDT-116 (MJW).

Author information

Authors and Affiliations

  1. Department of Otolaryngology/Head and Neck Surgery, Henry Ford Health System, 1 Ford Place, 1D, Detroit, MI, 48202, USA

    Maria J. Worsham & Alyssa Botttrell

  2. Department of Pathology, Henry Ford Health System, Detroit, MI, 48202, USA

    Usha Raju

  3. Department of Biostatistics and Research Epidemiology, Henry Ford Health System, Detroit, MI, 48202, USA

    Mei Lu & Alissa Kapke

  4. Wayne State University, Detroit, MI, USA

    Alyssa Botttrell

  5. Department of Head and Neck Surgery, Wayne State School of Medicine, Henry Ford Health System, 1 Ford Place, 1D, Detroit, MI, 48202, USA

    Jingfang Cheng

  6. Royal Gwent Hospital, South Wales, UK

    Varsha Shah

  7. LabMD, Inc., Atlanta, GA, USA

    Adnan Savera

  8. Department of Pathology, George Washington University, Washington, DC, 20052, USA

    Sandra R. Wolman

Authors
  1. Maria J. Worsham
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Usha Raju
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mei Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alissa Kapke
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alyssa Botttrell
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jingfang Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Varsha Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Adnan Savera
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Sandra R. Wolman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria J. Worsham.

Electronic supplementary material

Below is the link to the electronic supplementary material.

(XLS 28 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Worsham, M.J., Raju, U., Lu, M. et al. Risk factors for breast cancer from benign breast disease in a diverse population. Breast Cancer Res Treat 118, 1–7 (2009). https://doi.org/10.1007/s10549-008-0198-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-008-0198-8

Keywords

  • Benign breast disease
  • Progression
  • Risk factors